MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
BIOLASE Total Non Current Liabilities 2011-2026 | BIOL
Annual Total Non Current Liabilities BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.69 M | 11.5 M | 354 K | 1.86 M | 2.22 M | 1.2 M | 618 K | 804 K | 956 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.5 M | 354 K | 2.8 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Penumbra
PEN
|
89.2 M | $ 335.9 | 0.49 % | $ 13.1 B |  USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 220.08 | -2.4 % | $ 15.5 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
2.44 M | $ 5.69 | 10.49 % | $ 180 M |  Canada |
 |
Quanterix Corporation
QTRX
|
21.5 M | $ 3.97 | 3.93 % | $ 169 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
AVITA Medical
RCEL
|
2.35 M | $ 3.98 | 3.65 % | $ 111 M |  Australia |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.34 | -1.11 % | $ 21.6 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 102.42 | 1.44 % | $ 1.3 B | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.6 | 0.97 % | $ 7.21 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 36.85 | 0.72 % | $ 1.14 B | USA |
 |
Smith & Nephew plc
SNN
|
4.04 B | $ 32.43 | 0.82 % | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Sensus Healthcare
SRTS
|
1.66 M | $ 4.18 | 5.56 % | $ 68.2 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.83 | 0.53 % | $ 210 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | Canada |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 27.05 | 0.71 % | $ 619 M | USA |
 |
TELA Bio
TELA
|
30.2 M | $ 0.69 | -9.35 % | $ 15.8 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 24.5 | -0.04 % | $ 1.67 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.67 | -4.17 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.36 | 9.26 % | $ 3.68 M | USA |
 |
Orthofix Medical
OFIX
|
83.1 M | $ 11.84 | 0.98 % | $ 469 M |  Curacao |
 |
InspireMD
NSPR
|
3.49 M | $ 1.76 | -1.68 % | $ 113 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 11.35 | -1.13 % | $ 1.53 B | USA |
 |
Myomo
MYO
|
275 K | $ 0.7 | -1.07 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.3 | -4.38 % | $ 135 M | Israel |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.72 | -4.86 % | $ 139 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.29 | 2.36 % | $ 382 M | USA |
 |
Outset Medical
OM
|
436 M | $ 3.53 | - | $ 53.7 K | USA |
 |
Varex Imaging Corporation
VREX
|
419 M | $ 10.71 | 0.85 % | $ 443 M | USA |